FAIRsharing is here! From our first incarnation, BioSharing.org, which focussed on the life sciences, we are growing into FAIRsharing.org, to serve users across all disciplines and support Findable, Accessible, Interoperable and Reusable (FAIR) data.
Standards > reporting guideline > bsg-s000663


deprecated LINCS Pilot Phase 1 Metadata Standards: Primary Cells

Abbreviation:LINCS 1: Primary Cells


General Information
This record was deprecated on Aug. 10, 2016 for the following reason(s): This standard was a pilot study for the LINC2 Primary Cells standard (https://biosharing.org/bsg-s000652) and as such has been superseded by this standard.

The LINCS Pilot Phase 1 metadata standards annotate reagents outside the context of the experiments in which they were used. The underlying theme among all cell types is their association with a tissue or organ from which the cells were derived.


Collected/Recommended By



This record is maintained by cchung  ORCID

Record added: May 18, 2016, 10:14 a.m.
Record updated: Oct. 22, 2016, 8:04 p.m. by The FAIRsharing Team.


In Collections

Support

General

Additional Information


Tools

    No tools defined


Schemas

No XSD schemas defined


Access / Retrieve Data

Conditions of Use





Connectivity

Implementing Databases (1)
Library of Integrated Network-Based Cellular Signatures Data Portal
The LINCS Data Portal provides a unified interface for searching LINCS dataset packages and reagents. LINCS data are being made openly available as a community resource through a series of data releases, so as to enable scientists to address a broad range of basic research questions and to facilitate the identification of biological targets for new disease therapies. LINCS datasets consist of assay results from cultured and primary human cells treated with bioactive small molecules, ligands such as growth factors and cytokines, or genetic perturbations. Many different assays are used to monitor cell responses, including assays measuring transcript and protein expression; cell phenotype data are captured by biochemical and imaging readouts. Assays are typically carried out on multiple cell types, and at multiple timepoints; perturbagen activity is monitored at multiple doses.

Implementing Policies

This record is not implemented by any policy.



Publications

No publications available